Shots: Esperion to receive $30M up front, ~$175M as sales milestones along with royalties from 5-20% on sales in the territory. Daiichi Sankyo will get exclusive commercialization rights to bempedoic […]readmore
Tags : Ezetimibe
Shots: The approval is based on P-III trial Fixed Combination Drug Product LDL-C Lowering program, involves assessing of Nexlizet vs PBO when added on to maximally tolerated statins The study […]readmore
Shots: Sandoz recalls ~636,000 of Losartan potassium and Ezetimibe prescription drug bottles due to failure to meet child-resistant closure requirements as required by the Poison Prevention Packaging Act, posing a […]readmore